Literature DB >> 9375892

Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura.

F T Saulsbury1.   

Abstract

OBJECTIVE: To examine O-linked glycosylation of serum IgA1 in children with acute Henoch-Schönlein purpura (HSP).
METHODS: The O-linked oligosaccharides of serum IgA1 from 28 children with acute HSP and 26 control children were examined by enzyme immunoassay using plant lectins with well defined carbohydrate binding specificities. The lectins included Artocarpus integrifolia (jacalin), Arachis hypogaea (peanut lectin), and Sambucus nigra (elderberry lectin). Jacalin binds to galactose-N-acetylgalactosamine (Gal-GalNAc). Jacalin interaction with this oligosaccharide is not influenced by the presence of sialic acid on the galactose moiety. Peanut lectin also interacts with Gal-GalNAc, but binding is inhibited if the galactose residue is sialylated. Elderberry lectin binds to N-acetylneuraminic acid (sialic acid).
RESULTS: There was no difference in the binding of jacalin to IgA1 from patients with HSP compared to controls (p = 0.5). The binding of peanut lectin to IgA1 was significantly higher in HSP compared to controls (p = 0.007). Since peanut lectin binding is inhibited by the presence of sialylated galactose, these results suggest diminished sialic content of the O-linked oligosaccharides of IgA1 in HSP compared to controls. Indeed, the binding of the sialic acid-specific elderberry lectin to IgA1 was significantly lower in HSP compared to controls (p = 0.004).
CONCLUSION: The O-linked oligosaccharides of serum IgA1 from children with acute HSP are deficient in salic acid compared to serum IgA1 from control children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375892

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Characterization of von Willebrand factor in primary pulmonary hypertension.

Authors:  M T Collados; J Sandoval; S López; F A Massó; A Páez; J R Borbolla; L F Montaño
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase.

Authors:  Tongzhong Ju; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-03       Impact factor: 11.205

Review 3.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

4.  Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Authors:  Michelle M Gomes; Hitoshi Suzuki; Monica T Brooks; Milan Tomana; Zina Moldoveanu; Jiri Mestecky; Bruce A Julian; Jan Novak; Andrew B Herr
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

5.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

Review 6.  Gastrointestinal manifestations of Henoch-Schonlein Purpura.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

Review 7.  Immunoglobulin Glycosylation Effects in Allergy and Immunity.

Authors:  Alexandra Epp; Kathryn C Sullivan; Andrew B Herr; Richard T Strait
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

8.  Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

Authors:  Michelle M Gomes; Stephanie B Wall; Kazuo Takahashi; Jan Novak; Matthew B Renfrow; Andrew B Herr
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

Review 9.  IgA vasculitis with nephritis: update of pathogenesis with clinical implications.

Authors:  M Colleen Hastings; Dana V Rizk; Krzysztof Kiryluk; Raoul Nelson; Rima S Zahr; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2021-04-05       Impact factor: 3.651

10.  Successful outcome of a corticodependent henoch-schönlein purpura adult with rituximab.

Authors:  Taylor Pindi Sala; Jean-Marie Michot; Renaud Snanoudj; Marion Dollat; Emmanuel Estève; Bernadette Marie; Yacine Taoufik; Jean-François Delfraissy; Thierry Lazure; Olivier Lambotte
Journal:  Case Rep Med       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.